9HGP | pdb_00009hgp

Human Carbonic Anhydrase II in complex with a synthetic aromatic oligoamide foldamer


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.05 Å
  • R-Value Free: 
    0.231 (Depositor), 0.231 (DCC) 
  • R-Value Work: 
    0.171 (Depositor), 0.171 (DCC) 
  • R-Value Observed: 
    0.177 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Structure-based design of an aromatic helical foldamer-protein interface.

Wang, L.Douat, C.Sigl, J.Sai Reddy, P.Fischer, L.d'Estaintot, B.L.Liu, Z.Pophristic, V.Yang, Y.Zhang, Y.Huc, I.

(2025) Chem Sci 16: 12385-12396

  • DOI: https://doi.org/10.1039/d5sc01826a
  • Primary Citation of Related Structures:  
    9HGP

  • PubMed Abstract: 

    The starting point of this study is the solid state structure of a complex between human carbonic anhydrase II (HCAII) and a helically folded tetradecaamide aromatic foldamer with a nanomolar HCAII ligand appended at the N terminus of the helix. In this complex, the foldamer is achiral but its handedness is biased by diastereoselective interaction with the protein. Computational analysis of the HCAII surface and inspection of the initial solid state structure led to the suggestion of main chain and side chain modifications of the foldamer helix that would result in an extension of the foldamer protein interface as well as in absolute helix handedness control. Molecular dynamics simulations validated several of these suggested modifications as potentially resulting in favorable foldamer-protein contacts. Five new Fmoc-protected amino acid building blocks bearing new biogenic-like side chains were synthesized. Nine new tetradecaamide sequences with or without the appended HCAII ligand were synthesized on solid phase and purified by RP-HPLC. The solid state structures of four of these sequences in complex with HCAII were obtained and validated the main design principles: (i) side chains can be predictably introduced at precise positions of the foldamer surface to create new contacts with the protein; (ii) side chains modifications do not alter main chain behavior and can be implemented independent from each other; (iii) some main chain units derived from quinoline-, pyridine-, or benzene-based δ-amino acids are largely interchangeable without altering the overall helix curvature in the context of a complex with a protein. An assessment of the K D values required the adaptation of an existing fluorescence competition assay and suggested that the side chain and main chain modifications introduced in the new sequences did not result in significant improvement of the affinity of the foldamers to HCA.


  • Organizational Affiliation
    • Department Pharmazie, Ludwig-Maximilians-Universität München Butenandtstr. 5-13 81377 München Germany ivan.huc@cup.lmu.de.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Carbonic anhydrase 2260Homo sapiensMutation(s): 0 
Gene Names: CA2
EC: 4.2.1.1 (PDB Primary Data), 4.2.1.69 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P00918 (Homo sapiens)
Explore P00918 
Go to UniProtKB:  P00918
PHAROS:  P00918
GTEx:  ENSG00000104267 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00918
Sequence Annotations
Expand
  • Reference Sequence

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Synthetic aromatic oligoamide foldamerB [auth D]15synthetic constructMutation(s): 0 
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.05 Å
  • R-Value Free:  0.231 (Depositor), 0.231 (DCC) 
  • R-Value Work:  0.171 (Depositor), 0.171 (DCC) 
  • R-Value Observed: 0.177 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 81.682α = 90
b = 78.97β = 90
c = 46.116γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
CrysalisProdata reduction
CrysalisProdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2025-10-15
    Type: Initial release